The ABCD regimen for Hodgkin’s lymphoma is one that has little impact on fertility. Even if chemotherapy was administered during pregnancy, the data analyzed 43 children aged 3-19 years whose mothers had received chemotherapy during pregnancy for hematologic malignancies (acute and chronic leukemia, Hodgkin’s disease, and non-Hodgkin’s lymphoma), 19 of whom had received chemotherapy during the first trimester of pregnancy. The authors performed a thorough physical examination and neuropsychiatric, hematologic, immunologic, and cytogenetic examinations of these children without significant abnormalities. 14 of the 43 mothers with Hodgkin’s disease were treated with MOPP (azacitidine, vincristine, methylphenidate, prednisone) or ABVD (adriamycin, bleomycin, vincristine, azacrynic acid) regimens during pregnancy. Five cases received chemotherapy in the first trimester of pregnancy; all five women were 4 to 17 years old at the time of the authors’ report and had no abnormal findings on follow-up examinations. However, the authors claim that the small number of cases is not sufficient to exclude the possibility of teratogenicity of chemotherapy. More information suggests that two years after chemotherapy is more appropriate for pregnancy. Many children with leukemia have grown up to have healthy babies, so you don’t have to worry too much. Besides, there are pregnancy tests! Don’t worry about it!